Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT03729323 Enrolling by invitation - Clinical trials for Type 2 Diabetes Mellitus

Motivational Interviewing in the Control of Arterial Hypertension and Type 2 Diabetes Mellitus

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the effectiveness of Nursing Consultation based on the assumptions and techniques of Motivational Interviewing for the control of Type 2 diabetes mellitus with associated diagnosis of Systemic Arterial Hypertension in primary healthcare.

NCT ID: NCT03719703 Enrolling by invitation - Hypertension Clinical Trials

Health in Childhood Following Assisted Reproductive Technology

HiCART
Start date: November 2018
Phase:
Study type: Observational [Patient Registry]

The purpose of this trial is to investigate the metabolic and cardiovascular health in children aged 6-8 years born after in-vitro fertilization with frozen embryo transfer

NCT ID: NCT03707561 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

RUS-registry of PH

Start date: January 2016
Phase:
Study type: Observational [Patient Registry]

Russian National Registry of Patients With Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a multicenter, observational study of the clinical course and disease management of PAH and CTEPH patients. designed to gather demographic, clinical and prognostic data of routine medical care in prospective manner for newly initiated treatment since Jan 2016. The internet-based registry (www.medibase.pro) fulfills high quality standards through several measures (planned minimum centre contribution of at least 10 patients per year, automated plausibility checks of data at entry, queries, monitoring with source data verification in >50% of participating centers). All consecutive patients diagnosed with World Health Organization Pulmonary Hypertension Groups (WHO Group I) PAH according to specific hemodynamic criteria will be enrolled in participating centers after signing the informed consents. Participating patients will be followed for a minimum of five years from the time of enrollment. It can be applied, among further purposes, for quality assurance: individual centers can confidentially compare their results with the combined outcome of the other centers. It is expected that the registry contributes to optimization of specific drug therapy for PAH and Pulmonary Hypertension (PH).

NCT ID: NCT03683186 Enrolling by invitation - Hypertension Clinical Trials

A Study Evaluating the Long-Term Safety and Efficacy of Ralinepag in Subjects With PAH Via an Open-Label Extension

Start date: September 2018
Phase: Phase 3
Study type: Interventional

Study APD811-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

NCT ID: NCT03677609 Enrolling by invitation - Hypertension Clinical Trials

Stanford Clinics Physician Mindset Training

Start date: January 4, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of a novel intervention for physicians to increase awareness about interacting with patients with pre- diabetes, diabetes, and hypertension. The investigators will measure health outcomes in patients as well as patient and physician satisfaction at Stanford Corporate clinics. The doctor-patient relationship has been shown to positively impact not only patient satisfaction, but also patients' physiological health outcomes. Thus, the investigators hypothesize that improving the patient-provider relationship would increase physician efficacy in regards to communicating and mitigating long-term risks to patients at risk for or suffering from chronic illness. The present study develops and tests a mindset intervention for physicians aimed at helping physicians prioritize connecting with their patients both in addition to and in comparison with a communication skills training for physicians.

NCT ID: NCT03663127 Enrolling by invitation - Hypertension Clinical Trials

Evaluation of "Beauty Drink" on Regulation of Blood Pressure Effect by Clinical Trial

Start date: July 26, 2018
Phase: N/A
Study type: Interventional

This is the report to assess the effect of supplementation with gamma-aminobutyric acid on blood pressure among people with mild hypertension. Overall, "Beauty Drink" consumption for 8 weeks could successfully reduce mean diastolic and systolic BP through the suppression of ACE that is linked to downstream suppresion of angiotensin II formation, which further decreases the sympathetic outflow that leads to hypertension.

NCT ID: NCT03639480 Enrolling by invitation - Hypertension Clinical Trials

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Start date: October 13, 2017
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of CJ-30061 compared with amlodipine/valsartan combination therapy and valsartan/atorvastatin combination therapy in hypertensive patients with hyperlipidemia

NCT ID: NCT03637192 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of High Altitude on Cognitive Function

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to High Altitude (2500m above sea level) on cognitive functions

NCT ID: NCT03637179 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (2500m above sea level) on pulmonary artery pressure and right heart function (Echo) under exercise.

NCT ID: NCT03637166 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude ("Säntis"; 2500m above sea level) on pulmonary artery pressure and right heart function (echo)